iBio, Inc. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Agency Agreements (2 contracts)
- Collaboration Agreements (2)
- Development Agreements (2)
- Indemnification Agreements (2)
- Settlement Agreements (2)
- Termination Agreements (1)
- Voting Agreements (2)
- Settlement Agreement and Mutual Release, dated May 17, 2024, by and among Woodforest National Bank, iBio CDMO LLC and the Company (Filed With SEC on May 20, 2024)
- Placement Agency Agreement, dated December 5, 2023, by and between iBio, Inc. and A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities,... (Filed With SEC on December 6, 2023)
- Form of Placement Agency Agreement (Filed With SEC on November 30, 2023)
- Termination Agreement and Release dated September 19, 2022 by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on November 14, 2022)
- Form of Irrevocable Proxy For Voting Control (Filed With SEC on May 12, 2022)
- Confidential Settlement and Mutual Release with Fraunhofer USA, Inc. dated May 4, 2021 (Filed With SEC on September 28, 2021)
- Second Amended and Restated Voting Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors (Filed With SEC on August 27, 2021)
- Collaboration and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)
- Collaboration, Option and License Agreement, dated August 23, 2021, by and between iBio, Inc. and RubrYc Therapeutics, Inc (Filed With SEC on August 27, 2021)
- Indemnification Agreement by and between iBio, Inc., John Delta and TechCXO, LLC dated July 13, 2020 (Filed With SEC on October 5, 2020)
- Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 19, 2020)
- Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 13, 2020)
- Form of Indemnification Agreement (Filed With SEC on April 1, 2019)
